Login / Signup

The ERA Registry Annual Report 2021: a summary.

Brittany A BoerstraRianne BoeninkMegan E AstleyMarjolein BonthuisSamar Abd ElHafeezFederico Arribas MonzónAnders ÅsbergPazit BeckermanSamira BellAleix CasesPablo Castro de la NuezMarc A G J Ten DamAlicja Debska-SlizienNikola GjorgjievskiRebecca GiudottiJaakko HelveKristine HommelAlma IdriziÓlafur S IndriðasonFaiçal JarrayaJulia KerschbaumKirill S KomissarovNadiia KozliukMilica KravljacaMathilde LassalleJohan M De MeesterMai Ots-RosenbergZoe PlummerDanilo RadunovicOlena RazvazhaievaHalima ResicOlga Lucía Rodríguez ArévaloCarmen Santiuste de PablosNurhan SeyahiMaría Fernanda Slon-RobleroMaria StendahlMiloreta Tolaj-AvdiuSara Trujillo-AlemánIeva ZiedinaEdita ZiginskieneAlberto Ortiz ArduanKitty J JagerVianda S StelAnneke Kramer
Published in: Clinical kidney journal (2023)
In 2021, 533.2 million people in the general population were covered by the ERA Registry. The incidence of KRT was 145 per million population (pmp). In incident patients, 55% were 65 years or older, 64% were male, and the most common primary renal disease (PRD) was diabetes (22%). The prevalence of KRT was 1040 pmp. In prevalent patients, 47% were 65 years or older, 62% were male, and the most common PRDs were diabetes and glomerulonephritis/sclerosis (both 16%). On 31 December 2021, 56% of patients received haemodialysis, 5% received peritoneal dialysis, and 39% were living with a functioning graft. The kidney transplantation rate in 2021 was 37 pmp, a majority coming from deceased donors (66%). For patients initiating KRT between 2012-2016, 5-year survival probability was 52%. Compared to the general population, life expectancy was 65% and 68% shorter for males and females receiving dialysis, and 40% and 43% shorter for males and females living with a functioning graft.
Keyphrases